Red Light Therapy Benefits/Protocols: Simplifying 10,000 Studies
Watch on YouTubeVideo summary
Vladimir, a Finnish dentist with over a decade of experience in photobiomodulation (PBM), has developed a specialized database to address the overwhelming complexity of researching this field on standard platforms like PubMed. Launched in 2016 with approximately 3,000 studies, the database now hosts over 9,590 entries, reflecting an exponential growth driven by lower entry barriers and cheaper devices. This tool categorizes research by condition, country, publication year, methodology, and specific parameters such as wavelength and treatment duration, allowing users to locate relevant data in minutes rather than hours. The platform also features tabs for global research statistics and high-impact publications, aiming to legitimize PBM as a scientific field despite past skepticism fueled by marketing failures like "ear lights."
The evidence within the database is assessed across three levels: basic mechanisms, secondary effects, and clinical applications. While basic mitochondrial research remains limited with a rating of 5–7/10 due to a lack of large-scale studies, secondary mechanisms like anti-inflammatory effects have strong consensus from animal and cell studies, earning an 8–9/10 rating. Clinical applications show robust evidence for treating oral mucositis, pain conditions, and diabetic foot ulcers, whereas areas like Alzheimer's and macular degeneration remain promising but not yet fully solidified. A significant challenge identified is the high heterogeneity in study parameters and poor methodological quality, with only about 10% of randomized trials from a 25-year analysis deemed adequate, highlighting a translational gap where animal studies often fail to predict human outcomes.
Despite these methodological issues, PBM is considered a viable option because it carries minimal risk, even while awaiting more definitive data. Safety profiles indicate that negative effects are rare; although high doses can harm certain cells or eyes—particularly regarding blue light sensitivity—red light may offer some protective benefits. Mixed results exist regarding tumor growth and potential tissue damage at high doses, whereas benefits for hypothyroidism have been noted. The discussion highlights a disconnect between sunlight and PBM research communities, suggesting that beneficial effects observed with sunlight in conditions like multiple sclerosis may be mediated by red light, warranting further investigation. Key research gaps include the need for replication studies across different indications, understanding dynamic effects on thyroid hormone secretion, and conducting rigorous trials for diabetic foot ulcers using photodynamic therapy.
Looking toward the future, research directions include studying low-effort interventions such as adding near-infrared to office lighting and addressing contextual factors like dosing levels. The conversation concludes with Vladimir's commitment to maintaining his PBM database as a hobby project containing thousands of studies, hoping to continue this curation effort despite potential future replacement by AI tools. He acknowledges the challenges of sustaining volunteer efforts for large-scale data management but emphasizes the importance of shifting toward high-quality, pre-registered human randomized trials to close the translational gap and provide clearer guidance for practitioners and patients alike.
Read the full video transcript
So my main goal with this database is to
compete with these usual
scientific search websites because with
my PBM database the studies are very
kind of easy to find and they are
categorized neatly and uh if you go to
the part with for example the
Alzheimer's disease studies they are all
next to each others. And there's one row
for one study. And on each row you see
the study title and from which country
the studies and when it was published
and what is the study methodology and uh
if it was actual like animal or human
trial. You see at least some of the
parameters also. So you can see like in
1 minute you can see stuff that you may
need half an hour with the um
traditional ways of searching for
information. Hello everybody. Welcome to
the light therapy insiders podcast.
Today I have a very special guest
Vladimiran who has a database on
photobiomodulation or red light therapy.
I have been referencing that database
for many many years now and almost every
article or video that I make uh
references through it his database
basically because I use it as research
and there are like 9 and a half thousand
plus studies in there right now. Welcome
to the show Vladimir. Uh thanks so much
for being here. First of all like can
you tell me a little bit about your
background and how this whole massive
project I will say it's truly a massive
project because cannot imagine how much
time goes into this uh how this all got
started how you got into this PBM
because I understand that PBM is not
your formal education background right
>> yes uh thank you for inviting me over
yes I've been doing uh like PBM related
things for maybe 12 or 13 years now. I'm
34 old. Uh I'm a dentist living in
Finland and uh I have a pretty would I
say random background to health things.
When I was in high school, like
something like 17 years old, I suddenly
got very interested in internet
discussions about health and I had a
plenty of free time that I spent online
reading like health blogs. Uh I used an
R RSS is it called RSS feed reader uh to
follow maybe more than 200 different
health blogs. Uh there were mostly about
nutrition
and u I thought that many of the authors
had kind of interesting takes on how to
improve health in different ways. I read
about like there were this ancestral
nutrition things and stuff about
different vitamins.
Sometimes I could have like spent an
entire week only browsing through
vitamin D research discussions
and other things. And then there were a
lot of different gurus who had their
like very
how do you say deep world views on
various
health things. Um one of these uh guys
that I followed was Raymond Pet and u he
has some pretty
interesting views on nutrition
especially. He claims that uh basically
almost all unsaturated fats are
undesirable and that sugar is healthy
and it's against the common sense
in many things. And he also said that
red light has a stimulating effect on
metabolism and that blue light has an
opposite effect.
And I even though he has some pretty
interesting and uh contradictory
the his views are strongly like
they oppo they're they are how do you
say in opposition to the mainstream
views. uh I found
his views on amino acids very
interesting
when I was maybe 20 years old. He wrote
about glycine and collagen and gelatin
like proteins or amino acids and their
possible effects on health. And then I
started reading about
those things and found that his writings
were pretty maybe credible on those
things. So then I thought that maybe
he has some
maybe that could be worth investigating
that claim about red light also. And um
at first I couldn't find any evidence
for his claims. So I kind of gave up and
uh I gave up and decided that maybe this
rape is wrong about red light. But then
a couple months later I did my search
again and then suddenly I found [snorts]
hundreds of studies
like supporting health effects of red
light and near infrared. So, I found a
keyword low-level laser therapy, and I
know this that I found out that there
were like at least 2,000 studies showing
health effects from red light or near
infrared light, mostly from laser light
sources. And at the time, while I was
reading health blogs, I had also started
my own health blog and it had some
popularity in Finland. So I decided to
write a lengthy article about the stuff
I could find about red light therapy. I
found the article cited maybe 100 or 200
studies on photobiomodulation and
different diseases like balding and
hypothyroidism and osteoarthritis
and various various things. And that was
in 2013. The reaction was pretty how do
you say most of the people were not
interested in the my content. I even
tried to reach
many medical researchers in my country
and many new newspapers to show them
that hey there is some interesting
research about red light. And basically
I got very little attention. And uh that
actually was the basis for my idea of
creating this database because I thought
that if I could just pile up all the
evidence, then maybe people would
believe me that this red blood therapy
is a worthwhile topic to maybe
investigate or talk about or maybe even
use in some situations.
So that is like my background. First of
all, I when I was in high school, I
started reading health stuff. Then I
ended up hearing about red light
benefits on metabolism. And then at the
same time, I was writing a health blog
and I tried to like raise uh attention
for this topic. And because nobody
seemed very interested, I tried to kind
of how do you say increase my intensity
by creating like more content through
this database and after that I went to
st study dentistry also. So basically I
had this health interest first and then
later I went to study health sciences or
dentistry.
>> That sounds good. and understandable and
I I get what you mean with the whole
development through rapid red light red
light near infrared what was the year
that you started the database Vladimir
>> started in 2016 so it's now 10 years old
and maybe 4 months
>> I remember I I think like you you
started out with maybe what I remember
like 3,000 studies because I hear that
number coded over the years right like
10 years ago it was like 3,000 studies
Then a few years ago, people were saying
like four or 5,000 and now I I I checked
again before this interview and I think
you're over 9,590
studies are in there right now.
>> Yeah, because like last year I guess uh
almost 1,000 studies were published. If
you go to the database and you use the
Ctrl and F search function and just put
the year 2025,
it gives almost 1,000 results.
So yeah, the output is increasing. So we
probably if we look like six years
backwards, maybe it was like only half
of the current number of studies.
And why do you think that is that it's
so I think even you have some historical
chart where it shows like it's almost
exponential the curve right why do you
think that is
>> I think that uh if you look for many
different uh subjects in pubmed from
almost anything and the research output
gets faster and faster so it's not only
PBM but of course PBM maybe when it got
becomes more popular and more kind of
how do you say believable for
researchers maybe they have a lower
threshold for like doing some of their
own research also and devices when there
are more available and maybe cheaper so
it's easier to conduct research and of
course I think when there is more basic
like original studies then there is like
more sense to write review articles so I
guess the rate of new review articles is
probably a little bit higher than the
like increased rate for of original
studies. So for many PBM related like
subjects there are a lot of systematic
reviews and meta analysis published
nowadays because there is so much
original research already to be
summarized in this reviews.
So there are probably many reasons why
the pace is increasing
but anyways I think the increased rate
is still kind of how do you say true
that we are getting relevant information
at an increasing pace and it seems like
a good thing for example myopia did I
pronounce it correctly uh
nearsightedness
Um for example there was almost no
research about PBM and myopia maybe 5
years ago and um during this last maybe
four years or something the research
output from China has been just
unbelievable
like they're publishing so many huge
trials
about prevention of myopia in children
that is pretty nice to see. So we 5
years ago we had almost nothing and now
we have like research data like with
probably thousands of patients already.
Can you tell me for the people who are
not so familiar with your database what
exactly you do because for each study
you have like a few you have two
categories right a more broad category
and a or specific categories or the
broad category maybe I health and then
this more specific goal maybe myopia or
age related macular degener degeneration
and there's a year a title and then you
have all the PBM specifics right like
the wavelength if there's a device
specific device used you list at power
output the treatment time etc. Can you
tell me for the the people who are not
so familiar with your database? Most
people I think even on our website and
our YouTube channel have not seen your
database. So can you give like a simple
explanation of
>> Yeah, actually it would be probably a
good if this uh podcast would have some
kind of a short video insert or like
embedded part because it would
demonstrate it visually. But um uh my
point is that um for those people who
want to know about the actual scientific
research about photobiomodulation
uh there is a lot of it and uh we are
talking about almost 10,000 studies and
if you look to you look if you look use
the usual ways to search for this
research it's like
uh these websites like pub PubMed or
Google Scholar and it's very difficult
through those websites because um for if
you want to learn for example like PBM
and Alzheimer's disease you get so many
search results and you only see the
titles and not actual content
and uh if you use the keyword
photobiomodulation and Alzheimer's
disease you might miss some studies that
because some studies for kind of forgot
to use the right keywords so you may not
find them easily. So my uh main goal
with this database is to compete with
these usual
scientific search websites because with
my PBM database the studies are very
kind of easy to find and they are
categorized neatly and uh if you go to
the part with for example the
Alzheimer's disease studies they are all
next to each others. And there's one row
for one study. And on each row you see
the study title and from which country
the studies and when it was published
and what is the study methodology and uh
if it was actual like animal or human
trial. You see at least some of the
parameters also. So you can see like in
one minute you can see stuff that you
may need half an hour with the um
traditional ways of searching for
information. So my point is to make it
easier to find information about PBM in
large amounts
and also
because it all of the studies are in one
place, it makes it possible to kind of
get this large overview about PBM
because if you go to PubMed and you want
to know how many studies there are that
have been studied and indic application
for PBM therapy. Um, I have a my
database has a tab for that summarizes
all all of the possible indications. I
found like 300 of them. But it's almost
an impossible task to get this large
overview
from PubMed because you would have to go
through like hundreds of pages of search
results and create your own tables and
notes.
So I guess those are the main purposes.
So it's kind of a library for PBM
studies that is easy to use.
>> Yeah, that makes sense. And I can tell
you from experience because I often go I
through many of these topics whether
it's like Alzheimer's disease,
Parkinson's or yeah even a specific eye
health safety or eye health condition
that it helps a lot the the overview
right because you can just very easily
see see whether there like five studies
on on like a given topic or maybe I
think like I went through wound healing
recently a few months ago and there was
like 300 so yeah I had to limit myself
but and Then for each of the studies you
see the the wavelength and the the
intensity of the light that is applied
and how long it is applied etc.
>> At least that's my goal. I have a lot of
data like missing because I've been a
little bit lazy. I should make it more
complete. But uh that's
goal for the future. But I can tell that
yeah, if I if I had to go through all of
these studies myself and collect read
read the entire paper, make sure that I
find all the information. Of course, you
get quicker with it in the time you so
you can you could probably do it very
quickly. But if every paper is written a
little bit differently and then it takes
a lot of time to find what device is
used, how is it used, what participants
were included, what is the study setup,
etc. I think you've done the the whole
industry great service with this the
this database because it makes searching
for different topics so much easier. You
also mentioned you had some tabs right
that's also included such as some
research stats uh PBM links etc. Can you
tell me a little bit about that? Yeah,
for example, there is a tab called
research stats. Uh the point was
basically I was I had a Finnish profess
professor and we wanted to write a
review article about PBN to a Finnish
language um medical journal and I wanted
to say that kind of give a short summary
of the uh PBM research in our review
article. I wanted to tell how many
studies there are about PBM, how many
randomized trials there are, how many
different study animals have been used
in those trials
and what are the main like most
important countries of PBM research, how
many studies are being published each
year. So all kinds of this kinds of meta
information about PBM research output. I
guess for researchers it's probably
interesting to know like who is doing
the research and what type of research
is being done. I guess that's just
something many people would like to
know. And if we had a school textbook
about photobiomodulation, I think we
would have that information like how
many human studies, how many mouse
studies and so on. So the research stats
tab just contains information about that
although it's outdated so I should
update it. Yeah, I was planning to talk
about the other tabs, but if you want to
ask something about research stats or
comment, please go on.
>> Yeah. Well, we can talk about the other
tabs as well, but I know that you've
also collected data about which
countries have most of the publication,
right? I think it would be like USA,
China, and Brazil would be near the top
right now among others. So, that's also
the type of information that people can
find in that database if you go through
the tabs. just like an inter
interjection. But yeah, I'll I'll let
you continue uh leading people uh
through the tabs and of course we we
will show them on screen as well because
the video editor they can pull it up and
and really show it the things that
you're explaining right now.
>> And yeah, the top one country seems to
be Brazil and then United States is the
like the second one and then China and
Iran are also pretty major countries.
But then the we have like dozens of
different countries. So it's a pretty
like how do you say it's maybe
distributed or divided pretty evenly
in like many places on earth. Uh but
yeah then earlier I wanted to make this
tab PBM in high impact journals because
when I talked to doctors about PBM 10
years ago like many people were saying
that I have never heard about red light
therapy
uh it's probably not published in good
journals. So I made a kind of task for
myself to see what kind of medical
journals are publishing PBM research.
And I found a lot of high impact
journals from the like- with very high
ranks in those medical journal rankings
also publishing PBM research and then a
lot of how do you say mid tier journals.
So my the point of that dab is just to
demonstrate that PBM is not something
that is completely unknown to a
scientific community but instead it is
something that is really present in a
lot of good journals.
>> And why do you think that is that people
outside the PBM community don't seem to
really be aware of the amount of
research that is done here and also high
quality research? hard to say. In
general,
maybe
in general people often have narrow
focuses and maybe they read like
newspapers more than scientific
journals. So even though there is like
PBM research being published all the
time uh if you don't follow
the research output in medical journals
all the time you may miss it like I know
one professor who specializes in light
and health and he has written books and
articles
and still he missed BBM entirely for
like many years
because I don't know it's
when you go to scientific library you
have can see like thousands of books or
maybe tens of thousands of books and
journals. So after all maybe there is so
much stuff in medicine that's easy to
miss like uh some singular topics and of
course maybe
in public discussion like maybe doctors
are not have they have been a little bit
maybe afraid of talking about these
kinds of therapies because for example
in my country we had this Uh, have you
heard about the ear light? The the uh
LED lamps that are put in the ears and
they were supposed to help with
depression. At first we had a lot of
hype for those that product and u people
were buying those ear lights and they
bed paid maybe €200 for those or
something like that. But then maybe two
3 years later the reputation of that
product
went like very bad. They like for
example the Finnish skeptic organization
gave them this like how do you say
quackery prize for being like
unscientific product marketing. So in my
country after that ear light people may
be especially like skeptic skeptic
uh when it comes to red light therapy
also because it seems as if we were
fooled by this ear light thing and we
don't want to get like fooled again.
So
I guess now we are
we want more solid evidence on red light
therapy before we accept it. So
uh for many years it's been very rare to
see very uncommon to see PBM mentioned
in Finnish newspapers.
They have a lot of articles about health
and nutrition but very seldomly
about PBM. But maybe this year and last
year the situation has changed a little
bit. Maybe because these are LED masks
for skin health. They have been become
so popular
and they have probably pretty good sales
nowadays. So I guess that's shifting the
maybe the narrative a little bit.
>> Vladimir, if we take a step back and
look at like your entire like the body
of evidence of 10,000 studies almost of
course we cannot go into specifics
because the specifics are very very
complicated with many different
biological mechanisms etc. But where
right now in terms of evidence do you
think that it's best for for now for PBM
and moderates and where do you think
there there's not so much evidence now
if can you give a broad overview of that
because you went through so much
research of course
>> if we start from the basic mechanism
things like I've been doing some summer
job in mitochondrial mitochondrial
research group and uh what I see is that
if we look at ba basic research on
mitochondria, there are like very uh
high impact research groups around the
world with huge
funings publishing
research on various like mechanisms
related to mitochondria, how they
function in the cell and how for example
circadian rhythm or vitamins or
nutrition affects mitochondria and then
then these results are being published
in very high impact journals like nature
or science or cell and when it when it
comes to PBM
we don't see anything like that so in
for PBM
the basic research we have a lot of
individual small studies
various research groups with probably
much lower funding ing uh levels uh are
doing studies with cell cultures and
investigating
the effects of light in different
situations. But I think we are still
missing the highly funded major research
groups doing their best research on PBM
mechanisms. So I guess that we have a
lot of theoretical background on how PBM
may function, but I still wish it could
become a scientific topic that
is like investigated by these
groups that have a long history of doing
impactful
research on cells and mitochondria. And
that hasn't happened yet. Of course, we
have this Dinoarus
uh theory of PBM function on cytochrome
C oxidase. We have data on light having
effect on nitric oxide um release from
compounds that store nitric oxide.
uh we have some like even
more how do you say elegant studies. For
example, we have this study showing that
PBM has some effects on cells even even
on those cells that have this knockout
of cytochrome C oxidase. So
we have maybe I would say from the scale
1 to 10 maybe the level of our knowledge
for PBM
uh basic mechanisms I would say it's
maybe something like five or six or
seven but it's far from 10 we need more
basic research I think and then that was
about the primary mechanism maximum the
first effects in the cells. Then when it
comes to what else happens after PBM,
uh we call them usually secondary
mechanisms.
For example, in many diseases and
situations, PBM seems to lead to
increased energy metabolism in cells. It
seems to [clears throat]
lead to decreased pro-inflammatory
signaling.
It seems to lead to various kinds of
changes in cellular cellular functions
and gene expressions.
So this um we have thousands of studies
from various animal models and cell
culture models kind of repeating the
same message. We have probably like
hundreds of research groups showing that
PBM decreased inflammation or that PBM
upregulated some energy metabolism
related things. So I think those
secondary mechanisms are pretty solid. I
would say we can talk about eight to
eight or nine out of 10. So just because
the mass of research is so high and we
have data from so many countries, so
many research groups and so many
different animals, species and different
models of disease. And it seems to, for
example, when it comes to like
anti-inflammatory effects,
it's being demonstrated in more than 100
different
and models of different diseases like
heart diseases, brain diseases, skin
diseases. So I think uh that kind of
type of
that level of knowledge is pretty strong
probably
and then the most important for us and
for actual treatment of humans is of
course the uh clinical research. So the
study data data that we are obtaining
from treating actual humans with actual
diseases
and uh for clinical data um I would say
that maybe for some diseases we already
have a plenty of
uh useful information for example for
cancer patients with this for example
radiotherapy related oral oral
mucositis.
uh of course we have just maybe I don't
know maybe 100 clinical studies I would
guess that's anyways it's a huge amount
I don't remember how many and uh then we
have quite a lot of research for pain
mus how do you pronounce muscular
um skeletal
pain like for example like we have
studies on neck pain, shoulder pain,
back pain. Uh
um what else? Heel pain.
Uh I'm probably missing something.
Fibromy and then other pain painful
conditions like fibromyalgia and
osteoarthritis pain. I think um we are
already having quite a lot of research
on those things. Then there are some
clinical indications that we have maybe
I would say the level of evidence is
maybe low to moderate or at least
promising. So maybe diabetic food foot
alers
are something that we are starting to
have maybe a good amount research at
least maybe not yet but gradually and
maybe Alzheimer's disease also we have
many studies showing benefit over
placebo and maybe uh age related macular
degeneration.
It's maybe not solid yet, but it's not
we have something like not not bad data.
But then
we but anyways PBM is being researched
for so many different indications
and uh we have only maybe would I say
maybe a handful of these indications
where we can talk about pretty strong or
moderate evidence and then another one
or two handfuls of research where we
have kind of promising
to moderate level of evidence and then a
lot of indications where we have just
maybe a couple of uh in clinical studies
that
do not
uh kind of that are not enough for a
solid evidence base. So now when we are
talking about 1,000 studies being
published every year, I think if we wait
for 5 years pro I assume that we are
going to be in a much better situation
and that's maybe one of my motos that
let's just wait a little bit so then we
can give more confident answers about
red light therapy effectiveness on many
things.
>> That makes sense. And maybe out of my
own cur curiosity, Vladimir, uh, when
people say that this is something that
you probably also see a lot in many of
these research papers is that there's
such so much hogenity between studies,
right? Even if you have like many
different studies on like the well
unlike Alzheimer, that may be a good
good example or Parkinson's disease for
the brain. Yeah. that the treatment
parameters are all over the place and
some people when will then make the
argument like this this device uses 1060
nanometers or this study and the other
study uses A10 and the other 904 for
instance so we cannot really compare
them but how would you respond to that?
Yeah, that uh BBM is quite a complex
treatment when you compared it to like
painkiller drugs. When you t like study
ibuprofen, you can like of course there
can be a v variety in dosing. You can
have like one or two doses or three
doses per day and it can be a different
amounts of milligrams. But for PBM one
research group is using entirely
different wavelength power density
fluence or for example the how do you
say the rhythm of the treatments. One
group is giving and the command to
patients to use PBM twice daily and
another group asks patients to use it
once per week and um the there are many
parameters that differ between
uh different research groups. So that
also makes how do you say the evidence
much more difficult to summarize. And
then we when one research group has a
positive result and another gets a
negative result then we cannot infer
very easily that like what is the reason
why this one result was positive and the
other one was negative. has it something
to do with wavelength.
For example, this 1,60
seems to be maybe more often associated
with positive results than maybe 850,
but uh we maybe don't know if it's
causalone, but um and then yeah, it's it
makes it so frustrating for to PBM
researchers that we are not going to get
those uh answers.
quickly. We probably just need a lot of
more data accumulating and then some I
don't know sophisticated
analyszis and I don't know
>> that's a very good answer. I'm also
struggling a little bit with this topic
because I completely agree with you
there that we need more data on the one
hand but on the other hand also it makes
it very I I I think the whole PBM
research is much more difficult by
because these studies have so many
different parameters and variables that
make it very difficult to compare and on
on some topics that where we do have
like 30 or 40 studies now it is kind of
used against the whole industry and the
whole research field, right? Because
people say, okay, even though you have
maybe 30 or 40 studies on the topic,
that study uses A10 and four times five
times per week and this study uses 1060
maybe once uh once every week. So kind
of almost like the evidence-based
medicine people who really want like
three randomized control trial with with
the exact same variables that confirm
like an outcome. They seem to be Yeah,
it it seems to make them more skeptical
towards PBM even though I can see it
going both ways basically.
>> Yeah, I understand like for I have been
so frustrated by how complex it seems.
So it's probably like happening to a lot
of people who try to understand PBM and
evaluate it critically. It's so
difficult to be confident
at least like the situation is improving
in the I almost I always think in the
context of like um
well how do you say reward versus risk
and uh at least for PBM the risk is
becoming smaller and smaller all the
time because the devices are getting
cheaper. So at least if you cannot get
complete confidence on whether PBM may
be beneficial for the thing you are
trying to use it at least it's much
cheaper to try than before.
>> Yeah that makes sense and you're
probably just confirming but you're
probably alluding to that there are so
many consumer devices on the market
right now and many LED based. I know
that you also have some publications on
that right with professor Hamlin uh led
versus
>> oh I just wanted to say that uh I
haven't written like anything during the
last couple of years that was maybe
eight years ago but my when I was a
blogger and when I wrote those articles
usually I had some kind of viewpoint in
my mind some perspective that hasn't had
not really got enough attention in the
field and there really was no good
article comparing LEDs and lasers and
there were so many uh PBM authors who
seemed to believe that you need lasers
for photobiomodulation.
So I was very happy that we ended up
writing that review article about the
topic. So it kind of demonstrated pretty
well that there are a lot of
head-to-head comparisons between LEDs
and lasers and in most of those
comparisons they seem to be uh equally
effective. So um it's kind of at least I
personally believe that uh LEDs seem to
be pretty good light source for PBM and
uh maybe even sunlight
and um maybe even incandescent or hogen
lights broadband lights probably work as
well although we don't have that much
research on them
>> that Makes a lot of sense. Yeah. My
question is after going yeah so many
years through all of that research is
there anything that really surprised you
cuz you now have like collected almost
1000 studies?
>> Let's see. There are like maybe various
kind of how do you say type types of
surprise for example like if we consider
like some treatment indication like
diabetic foot ulcers and PBM one of
things I was surprised was that even
though we have a lot of uh like quite
many clinical trials there are so many
bad ones.
So that's one thing that I'm pretty
annoyed by that some studies have really
huge difficulties just even reporting
basic parameters maybe doing some uh
just usual uh like reporting of results
and everything and there's a lot of bad
methodology out there. So even though we
have like almost 10,000 studies, if we
remove the poor ones, we are left with a
much smaller number of good studies. So
maybe that and then there are like some
studies have spin. By spin I mean that
some studies report negative results but
in the conclusions they write as if it
was positive. Well, when people talk
about medical research, often people
have very high they think very highly of
medical research and especially clinical
research, but actually I think only part
of it is good and then there are is
maybe too much of the bad quality out
there also. So maybe that's one thing
that I don't know if it surprises me but
um at least something I wanted to
mention. Let's see something else. I
know I need to think probably probably
there are many things but I just can't
get in my mind. Uh one is maybe this is
also maybe just something very
subjective but I've been always looking
at the whole picture. I guess I I'm
interesting interested in PBM and
everything related to PBM but it's just
so funny that very often researchers
take some very very narrow
like point of focus and then they do all
of their research about that one
specific thing. It can be like PBM and
healing of scratch wounds in cell
cultures or that could be PBM and
Parkinson's disease, PBM
and Aculus heel. So it's something very
specific. I don't know my kind of in my
ideal world I think all research
researchers should spend maybe five
years just reading studies and going to
actual research after that when they
have already kind of spent enough time
to get a good overview on the things
they want to focus on. that would
probably help to
plan useful research um methods or kind
of research settings. Uh think about the
most important things to spend your
resources on. It's sometimes funny that
we have like maybe I don't know 100
studies on PBM and the Achilles heel of
rodents. Of course, they are usually
measuring slightly different things, but
I don't know in my ideal world, we would
have almost only well
done like high quality human studies
that are run randomized and binded and
well reported and pre-registered
and uh with sufficient sample size. And
then we would skip most of the animal
studies just because they are often so
poorly translated
to humans. So it's not that useful after
all. But I don't know that was some kind
of um what do you say criticism of the
research culture but I don't know if
that was the best answer to your
question about surprises but
>> it is something I also see and uh yeah I
go to some of these conferences uh one
one of them I was like one and a half
years ago the world's federation of
laser dentistry in Brazil actually where
you see people who have made entire
careers of 10 20 years of only light
therapy for peroderal titis for instance
or denton hypers sensitive or or uh
implants or what whatever I will say
that generally the the people who focus
on such a topic don't seem to be aware
of the entire dynamics that light
therapy can have on many different
outcomes. If we take a step back and uh
talk about that distribution right you
just mentioned animal studies there's
also of course a lot of in vitro uh
petri studies etc or more broadly
foundational research and there are
human studies yeah and I emailed you
about this a few years ago and actually
you had the same argument like that the
animal studies don't always translate
into the same outcome in human studies
can you tell me a little bit more about
that and also about what your ideal
research would be yeah you do manive Of
course, human studies with sufficient
participants pre-registered so that
people can like fetch outcome afterwards
or yeah that you at least have
accountability that it needs to be
published. Yeah, I imagine that would
reduce like publication bias and some
other criteria.
>> Yeah. Um okay, let's see. Uh I think I
just have to the question was uh hey um
>> yeah on the distribution between in
vitro animal and human so yeah
>> uh so I'm not an expert in this uh
subject of translational gap but it's
very well known in medicine that for
many uh diseases say maybe Alzheimer's
disease Parkinson's disease is stroke.
Yeah. Especially many brain conditions,
we see that we can we may found even
like 100 different drugs that seem to be
beneficial for mice with the animal
model of this disease. But then suddenly
when we get these clinical trials in
humans then like basically all of them
fail and we are left with no drug for
Alzheimer's disease because all of them
failed. So that's a big issue in medical
research and
uh I'm not really sure what is the like
list of arguments why is this so huge
like this difference between rodence and
humans which would explain like what are
the explanations why so many drugs and
treatments seem to work in animals but
not in humans but it's a I suppose it's
a subject that you may find a lot of
information from the literature and
nowadays you can use AI to maybe ask for
some [snorts]
knowledge about this thing. Um and uh
basically when you talk about if you
talk with people who write treatment
guidelines that um I think if you want
that some treatment is utilized in like
actual health care usually happens in a
way that the guidelines are written and
then they notice that oh we have good
evidence for maybe I don't know PBM and
uh PBM and myopia and um but if we want
to end in that situation where some
those groups writing the guidelines
conclude that PBM is beneficial for
myopia or Alzheimer's disease or
diabetic food ulcers. We need to have
solid evidence and basically the
evidence they look at is only only
randomized trials. They don't care at
cell trials or m mouse trials or rat
trials or rabbit trials at all. They
also don't really care about um single
arm human trials with no comparison
group. uh basically they care about only
proper randomized trials and uh then if
we I don't remember the actual numbers
of studies for each indications but if
we think maybe PBM and diabetic foot
ulcers and uh group starts evaluating
the strength or the certainty of the
evidence of BBM M for diabetic foot
ulcers they first do the literature
search and find all the relevant studies
and how many they will find I don't know
maybe 25 studies that are randomized it
could be maybe less I'm not sure I don't
remember uh but if we now cons maybe if
we assume it was 25 they will go through
various types of checklists to evaluate
the risk of bias in these studies. They
see if the randomization
was described well in the paper. They
uh go through to see if the group
allocation was like truly blinded. There
are like a lot of things that can go
wrong and in the if we consider the
whole medical evidence that we have like
the tens of thousands of randomized
trials published in medicine. The not
many trials are actually low risk of
bias. Most randomized trials have issues
that could be corrected just by kind of
having maybe some methodologists
in the research group that really make
sure that the study is well done and
that really doesn't happen that often. I
think that's one of my criticism
that uh if we want PBM to be a part of
actual like treatment guide guidelines
for diseases we really need to focus on
doing good quality studies and some of
the research groups are doing it but so
many are not. So
uh I hope there actually there are like
there is this uh field called meta
research that kind of there is it's like
study doing research about medical
research and uh there has been research
evaluating the long term like longtime
trends in medical research like whether
the quality of clinical studies is
improving or not. And I think the what
we can conclude is that the number of
good studies used to be like okay the
proportion of the good studies used to
be pretty low but it's increasing.
Uh so probably if we look five or 10
years to the future,
we will have pretty high quality
uh studies
on average because the trend is towards
positive like better quality. But still
we are far from perfect. And uh the
thing is that uh maybe 10 or 20 years
ago the guideline groups were not as
critical as nowadays. But nowadays they
really notice all of the like mistakes
and all of the limitations of the
studies. They are they have become much
more critical nowadays. So it's not so
easy to how do you say introduce a new
treatment because the requirements are
higher and yeah there is this one study
about this research trends I actually
found it's written by Mario line Catalan
in Brit British medical journal open in
2019 and it had pretty interesting data
on on this issue. I sent you a link so
it can be
>> we'll include it in the description
below as well this study and show it on
the screen. What what's in it that study
Vladimir?
>> This study I sent the link it analyzed
it is a study that analyzed uh 20,000
randomized trials starting from 1990 and
ending in 90 ending in 2015. So it's a
like uh how do you say duration of 25
years and it looks at how the study
quality
improves over time and uh basically it
shows that methodology improves but it's
still far from perfect.
So basically
in 1990 how to say 1990
the only 2.6%
were of adequate methods like and uh in
the end of that followup it was 10.3%.
So only 10% of the student the most
recent studies were evaluated as
adequate
>> and for the people listening that
matters a lot because yeah of course
there's going to a huge amount of
funding towards medical research and
ideally we want studies that have a good
setup because then would set up good
methodology because then we're able to
use them for medical treatment
guidelines right if I understand your
argument correctly flammir then by
creating so many ma maybe yeah arguably
too many animal studies right now in in
the PBM field and because these animal
studies don't always translate well to
the human study so you don't get the
same outcome in the animal study as a
human study it can be viewed as a yeah a
waste of resources basically because no
matter how many animal studies you do
you still need to do the human study to
get the real outcome right
>> that's the point so if we get 1,000
studies each year so maybe only I I
don't know 30 or 60 of them are really
useful for us and the rest are maybe
useful in some ways but not in this
direct way of kind of impacting
guidelines. So what we need is more of
human trials and not any human trials.
We need good quality human trials. A
related question to that I have about
the methodology is that in the PBM you
already mentioned this but in the PBM
fields retinal therapy often many
parameter treatment parameters are also
not mentioned right such as for instance
they don't measure well they may may
mention with a laser how many jewels of
light goes in there but not the really
get you may not get like a real
measurement of like the the light output
in mill of centime squared and or you
may not get the treatment area for
instance and that also severely limits
how much how useful studies are even if
they're they're promised
>> and yeah so for the is it repr rep how
do you pronounce reproducibility or
something uh yeah you need all of the
relevant data so the other research
group could create a similar study and
get this um how do you say um it's not
repetition um replication of your trial.
It's and uh then I think there could
even be like factors that we do not even
how do you say take into consideration.
So what if the time of day matters? What
if it's a different thing to give PBM in
the morning or in the afternoon? It's
almost never reported. But if it's very
relevant, we may have like almost 10,000
studies that miss something very
relevant. So we still may uncover some
contextual factor factors that can be
very relevant at least. Uh I don't know
you know Glenn Glenn Jeffrey I guess.
>> Yeah. Yeah. I was just about to bring
that up because he seems to think that
in the morning or evening it it's a
different effect, right? What do you
think about that? And of course, I know
you cannot give me the answer because we
don't really have this we don't have the
exact data to determine that. I think uh
right now to say it's it's this way like
it really matters or it doesn't matter.
>> Yeah, I think that Jeffy's group had
some results that kind of uh point to
the direction that morning PBM could
have better in better in effect and then
afternoon PBM. But I think Russian
researchers focusing on this brains
drainage system, they compared maybe
night to night PBM and day PBM or
something. And I think they had
something some different
uh conclusions also. I I cannot say what
is the kind of whole picture that we can
paint from the research at the m moment.
I just don't remember. I think they may
be reporting some benefit from night PBM
but I'm I may misremember
>> and even then even if they had reported
it still on the back of my mind there
would be the idea like I still would
would have wanted this to be tested with
different devices also on different
treatment parameters in different times
of the day right maybe there's an effect
with one device but if I use like a V
light device on the brain during the
morning or evening maybe there's a
difference or with these whole uh body
panels what the effect would be there uh
if we try to measure it with the morning
or evening. So even if there are a few
studies, there's the whole issue of that
there are so many variables that still
difficult to draw a super solid
conclusion. But I certainly understand
what you mean here. Yeah, with the the
timing of the day aspect.
>> Yeah, it's difficult to plan for like
what would be a good direction in PBM
research and what should we kind of try
to do with all these different
parameters because I don't know I don't
have a good idea. Of course, we need a
lot of comparisons, different doses,
different wavelengths, different beam
sizes. Yes, I think recently on social
media I read that of course in many PBM
studies you we have been using very
narrow very small beam of light and then
we have all these like p very large
panels and also that have very huge beam
of light and does it matter? There was
somebody that had this idea that um it's
maybe more beneficial to have a small
beam of light directly pointed to that
specific part of body you want to treat.
So the body would kind of how do you say
direct the blood stream and resources to
that place and not everywhere else. So
that's a good hypothesis.
Although all we do have full body PBM
results with positive result full body
PBM studies with positive results as
well. So I think there is a strong kind
of point for full body PBM as well and
it seems very if we consider our
evolutionary history of getting sunlight
it seem it makes sense also. Yeah there
are many factors that we can speculate
about.
>> Yeah. Do you have an opinion about that?
The sunlight versus PBM or
>> I wrote the article about sunlight and
that's one thing I was surprised like
PBM researchers
don't know much about sunlight and
sunlight researchers don't know much
about PBM. So it's two research
communities that kind of they should
overlap, they should communicate,
but they basically don't know each
other. So when you read articles about
sunlight, they never seem to mention PBM
or okay just sometimes they do but very
very seldom. It's very weird. This is
like the end result of this system where
we are so narrowly focused.
>> I do know that your database it has a
specific header for sunlight right with
sunlight studies which I think are very
very important. Yeah, I think the
sunlight is correlated to many good
things.
So I think it's relevant to keep in mind
when we talk about PBM and it's also
probably good to keep in mind. For
example, PBM seems to be bene seemed to
be beneficial to maybe multiple
sclerosis in some mouse models and at
the same time sunlight seems to be
correlated with less multiple sclerosis.
So could the beneficial effect of
sunlight okay we don't know if it's
beneficial effect or only correlation
but uh if we assumed it was a a
beneficial effect of sunlight uh would
it be mediated by red light maybe it's
something that PBM research could be
useful to give some answers
because we could study red side effects
on multiple multiple sclerosis
development or or progress of that
disease.
>> Yeah, makes sense. And what I know I
wrote an article about the multiple
sclerosis and PBM or red therapy last
year and there's also the issue of the
heterogeneity of the studies. So
basically right now all of the most of
the studies they have a very different
treatment protocol which makes yeah
makes it a lot more difficult.
>> Yeah. And that's one of the indications
where we basically do not have
sufficient research yet. Maybe in the
future
>> because I think like some of them use
like acupressure points for treatment
with lasers and then there's another
setup completely different treatment
area and different treatment methods and
another study etc. Then switching to
another topic Vladimir what about
studies with like no effect or even
negative effect which which is I think
maybe even more important. Let's go into
that one first right now and there's a
lot of discussion about around this
right now. What do you think that are
the most most important side effects or
potential side effects or even proven
side effects that are out there for PBM?
>> Good question. First of all, I have um I
have seen very little negative effects
from PBM. So in general it seems to be
like super rare to get any uh big
negative effects from PBM. Uh I have a
part in my database that is about safety
of PBM. And if I go through it I see a
couple of negative results as well
though some of those seem to be cell
culture studies. And of course, of
course, we know that some cells can be
vulnerable to very high doses or and for
example, eyes can be vulnerable to light
induced damage. Although they are much
more sensitive to blue light than red
light. And it seems that red light can
even protect eyes a little bit from blue
light induced damage. But anyways, of
course, we know high doses can be
harmful in in some contexts, but we I
cannot recall much data demonstrating
real harms and we have a lot of null
results. uh in which PBM did not have
any notable effect compared to control
group or placebo group. But uh actual
negative results very very difficult to
remember the only thing that I can now
like that I have in my mind is maybe
mice and tumor growth. So there are
studies where they uh how do you say in
um make tumors grow in mice and then
they report what happens if they also
gets PBM. Uh in some studies PBM
increases tumor growth which is probably
bad and uh in some studies they
showed like decrease into more growth.
So the results are mixed. If I had a
cancer, maybe I would not irradiate the
that cancer area. I don't know. And of
course, maybe some endocrine glands
could also be sensitive to light.
testicles. Maybe there are some negative
results in animals that high doses of
red light can maybe cause some tissue
damage to testicles.
But then on the other hand, thyroid
gland, I guess we are mostly seeing
beneficial results on hypothyroidism.
So maybe I would consider PBM as a
positive as a possible uh treatment for
thyroid problems instead of possible
harm possible source of harm.
>> Yeah, but that makes a lot of sense and
I would agree there very often people
like ask in our Facebook group about the
cancer and red light therapy. That's
like the only topic I Yeah, of course
I'm also not willing to make a
commitment there and tell somebody like
go use red light therapy because I don't
want to be responsible for the
consequences there. But I think that's a
very good guideline that if you have
cancerous tissue somewhere not to use
red therapy directly on it. If you could
create maybe one or two or three studies
in an ideal world and you would
unlimited funding, what would you like
to see research because you have so much
Yeah. background knowledge now about the
different options that we have and do
not have. More importantly,
>> I would probably want just to have a
good replications on many different
indications.
When I became interested in PBM, I was
so interested about the possible effects
on hypothyroidism.
uh people are eating thyroxine
T4 hormone for life and then there are
studies demonstrating that people could
maybe even get rid of the um lifelong
medication. So I if I had a money I
don't have any like super
um how do you say um grand plans I but
that would be one thing I would
want to research and I would also like
to study the dynamics of the effects
like I would like to know if you give
red light to thyroid does it lead to any
acute effects on thyroid hormone
secretion over 1 hour or 24 hours. I
guess we don't have sufficient research
on that then uh I would maybe just
support the Alzheimer's disease research
because there have been so many
individual small studies reporting like
in improved cognitive test results over
placebo. So it seems that maybe PBM
could be beneficial for mild dementia
and it would be a huge thing if that was
true. So and uh yeah one of the things I
would actually want to resol search that
is not actually PBM but it's P PDT
photodnamic therapy is there was one
study in which basically
people had very severe um uh diabetic
foot ulcers and one group had had uh
just usual care and one group had red
light and metallium blue. So this
combination is basically photodnamic
therapy and in this group basically
everybody
uh could keep their feet and in the
usual care group basically everybody was
amputated. it was a huge uh difference
between the groups but as far as I
remember it was not a properly
randomized trial and it had maybe I
don't know maybe 35 participants so I
would like to see a good study
like replicating that
uh same setting
with good methods and let's see if
there's something else.
It would be nice to see more of those
studies where they just add near
infrared light to office lighting like
and see if it has some minor maybe
beneficial effects. I think we had one
study
uh
maybe one two years ago or something. Do
you remember what I'm talking about or
do?
>> Yeah, I think Dr. Glen Jeffries also has
some studies on this. Now I don't know I
don't remember the exact year but I
think also with adding some incandescent
or halogen lighting in inside the office
space with very positive effects.
>> I think I need more than like one minute
to find that study but anyways I think
it would be just because it may be a
little bit boring for people to grab
that PBM light and do their 5 minute or
15 minute therapy session. It would be
nice to see more of the research on this
loweffort things like invisible near
infrared that you get maybe
automatically from your desk and you
>> I know that that was one of the original
uh recommendations of Dr. Ray Pets, who
you of course started with in the
introduction of this interview because
he's a big proponent of having the well
he always mentions like the incandescent
lighting and I think he like back in the
day recommended like six 500 watts
incandescent over light and just
activating them for like 1 minute even
if every hour or so. Len Jeff has I
think with the incandescent lighting at
the desk that showed some benefits
instead of the yeah the more blue blue
light dominant LEDs or flu reset
lighting in office set.
>> I think Ray Pet had a few arguments for
that point that long short days are
associated with problems. So, if you
kind of could uh make the night a little
bit shorter, for example, by introducing
a little bit of extra light, extra red
light, it would be good. But yeah, it's
been so long so since I've been reading
Pete. But yeah, but yeah, unfortunately
I have a my personal document with a
list of possible like good uh studies I
would like to see, but most of I have
like four 30 or 40 maybe no actually
even 50 study ideas but only five of of
them are something to do with PBM
because um yeah as a matter of fact I
read about PBM and I do this database
but I really do I'm interested in many
other topics as well. So PBM is just
maybe one of my major points of
interest.
>> Yeah, that makes makes a lot of sense.
Then we'll wrap it up here. Vladimir, is
there anything else that you would want
to share or maybe an important topic
that I forgot to mention? Of course,
we'll be including the link to your
database below. look at it and yeah
there many of the tabs are on the bottom
right so that you can go to the
specialty or to the statistics etc but
it's a little bit overlooked by some
people I think but yeah the the tabs are
also very important there
>> yeah uh maybe two points uh the one is
about negative results that in the past
there was this like article it's been a
long time since he wrote this but Yan
Tuner from from Sweden published this
analyszis of many negative results in
PBM and showed that it was quite
commonly related to some like very low
dosing and so on. So he could find some
kind of plausible believable
explanations for some of the negative
results. But then and uh nowadays some
meta analyszis do subgroup analyszis.
For example, they compare
um studies with higher doses and studies
with lower doses and try try to find if
for example if higher dose is associated
with more benefit results more
beneficial results. But I think we are
still far from understanding
all these contextual factors. So I hope
that maybe during the next five years we
learn a lot about that. That was the
point one. And then the second one, it's
about the PBM database. I do it as a
hobby. And uh maybe two or 3 years ago,
I spent a year where I added all of
those emojis and uh a lot of extra
information
and so on. But maybe for one or two
years, I've been like uh very lazy with
this PBM database and I'm hoping to get
back to a good good pace. I hope I it's
after 10 years of doing this as a hobby,
it's becoming a little bit boring.
Sometimes I add 100 studies during one
weekend and I still I feel like that
like I didn't see anything new. I've
seen this all before. So then nowadays I
read about so many different topics like
I try to learn social dancing and music
skills and
um so I hope I can still re keep my uh
eagerness towards PBM up so that I can
do this after my work because I do like
whole full full how do you say full week
work as a dentist? Um and um then I've
been thinking also if a artificial
intelligence will have some effect on
this whole thing because uh maybe in the
future this database could be replaced
by AI because the it's becoming
increasingly good at browsing through
the studies and probably even now if you
use the deep research you can get a lot
of useful information about for say
let's say for about PBM and Alzheimer's
disease. So
I'm not sure what is the future of PBM
database if the AI becomes very good.
Um it could be that I can use AI for
updates of database or maybe it becomes
entirely useless at some point but I
think it will not happen during the next
one year may or maybe even two years. So
I think I'll keep on updating it until
it be maybe becomes less useful for
people because so far I've heard many
researchers saying it's useful for them.
So and lay people as well. So I guess
it's probably worth keeping it up. It's
interesting that you mentioned AI
because I just one or one or two months
ago shot a video comparing the AI deep
research and really try trying to make
my search term I make the search term
completely visible on in in the YouTube
video and then the results and then my
own manual methods and results and then
on three different topics. So that will
come out on the on on the light therapy
insiders uh YouTube channel and yeah I'm
very curious to see where your database
is going in the next u few years. Is
there any help that you need with that?
I know that our mutual friend Aaron
Rogers is already sometimes chipping in
there but yeah I know that it's you
doing most of the work. We are talking
about some collaboration ideas now
between I and Waltz W the world um
world organization for BBM but uh yeah
I've been thinking about the
collaboration for many times but when it
comes to adding new studies basically I
want to go through through the new
studies so I see them and it's quite
difficult to keep it uniform if somebody
else does it differently. So it would
require a lot of kind of um time doing
it together first. But it of course it
could be possible. But I haven't felt it
as kind of necessary.
But for making the database more dense
with information, it would be useful if
somebody would help. But yeah, I don't
know. I haven't been thinking about that
too much so far. And other people also
have their kind of projects. I don't
know. For me, it's kind of exciting to
have this one person massive projects.
But if somebody had an assisting role,
how long they would do it eagerly until
they felt like it's not kind of exciting
enough? Because
people usually, I don't know, may don't
want to do just help somebody for
hundreds of hours for free. It starts to
feel like work.
>> Yeah, that makes sense. And I think it
is yeah you deserve a big huge thank you
from the whole community because you've
been doing this as a hobby or as a form
of charity almost I would say uh towards
the whole community. So thanks so much
and I know I'm talking from from the
perspective of many people that use your
database almost every day or sometimes
people weekly but in my case it's
probably several times a week that I get
in there. So thank you so much and again
people check out the the PBM database
below in the description. Thank you so
much for all the work work that you do.
>> Yeah, thank you and I'm very happy to
hear that you found it useful and work
like using regularly and thanks for the
talk and um if you feel so we may talk
again at some point in future.
>> We certainly will I think. Yeah. Thanks
so much.
>> Yep. Oh, okay. Bye.